HIND — Vyome Holdings, Inc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1427570 ·
Last close
$2.03
Market Cap
$14.25M
52W High
$6.56
52W Low
$1.75
ADV30
16,650
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 26,955 | 11,658 | -862,566 | -685,556 | 9,176,362 | 7,887,510 | 1,864,656 |
| Mar 2026 | 31,591 | 16,645 | -1,129,940 | -962,910 | 10,185,446 | 8,795,783 | 2,144,125 |
| Dec 2025 | 36,551 | 22,066 | -1,355,074 | -1,063,974 | 6,497,177 | 4,982,333 | 2,735,160 |
| Sep 2025 | 34,627 | 18,050 | -868,777 | -8,595,300 | 7,045,396 | 5,707,012 | 3,126,936 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,120,663
Investing CF
$1,466
Financing CF
$6,266,354
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.32
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-88,526,485
Inventory
—
Receivables
$140,843
ST Investments
—
EBIT TTM
$-11,057,114
Pretax Income TTM
$-11,154,475
Interest Exp TTM
$97,361
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$129,725
EBITDA
$-4,205,649
Free Cash Flow
$3,641,658
Enterprise Value
$7,851,187
Total Cash
$7,887,510
Total Debt
$17,310
Shares Out
7,018,528
Trailing EPS
$-1.61
Book Value
$0.86
ROE
-999.2%
ROA
-48.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 319,714 | -2,747,037 | -10,262,007 | 6,497,177 | 2,735,160 | 2,442,059 | -3,748,853 |
| Dec 2024 | 256,944 | -1,006,340 | -1,447,461 | 1,381,561 | 5,772,594 | -4,391,034 | -614,136 |
| Dec 2023 | 415,940 | -767,718 | -719,920 | 1,421,251 | 7,506,423 | -6,085,172 | -563,983 |
| Dec 2022 | 382,865 | -1,104,183 | -1,255,298 | 1,789,415 | 7,154,503 | -5,365,088 | -362,879 |
TTM Snapshot
Revenues TTM
$-761,695
NetIncome TTM
$-12,698,917
OpCashFlow TTM
—
Assets (Latest)
$10,185,446
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TVRD | Tvardi Therapeutics, Inc. | $14.41M | $1.08 | — |
| KTTA | Pasithea Therapeutics Corp. | $14.73M | $0.44 | — |
| BFRI | Biofrontera Inc. | $13.65M | $0.92 | — |
| KPTI | Karyopharm Therapeutics Inc. | $13.61M | $0.60 | — |
| SYBX | SYNLOGIC, INC. | $13.47M | $1.10 | — |
News headlines (Yahoo Finance, 1h cache)
Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908, its Novel Topical Mycophenolate Program Targeting the $20+ Billion Ocular Inflammation Market
2026-10-05 12:00 · Yahoo
Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet
2026-08-25 12:00 · Yahoo
Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
2026-07-01 12:00 · Yahoo
Vyome Holdings Inc (HIND) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
2026-03-30 23:00 · Yahoo
Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
2026-09-14 12:00 · Yahoo
We're Not Very Worried About Vyome Holdings' (NASDAQ:HIND) Cash Burn Rate
2025-12-29 11:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.